5-Isoquinolinesulfonamide derivatives. 1. Synthesis and vasodilatory activity of N-(2-guanidinoethyl)-5-isoquinolinesulfonamide derivatives
- 1 January 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (1) , 42-46
- https://doi.org/10.1021/jm00121a009
Abstract
Two novel series of N-(2-guanidinoalkyl)-5-isoquinolinesulfonamides, 2 and 3, were prepared. Many of the compounds possessed vasodilatory activity when injected locally into the femoral artery of dogs. The most potent compound, 1-amidino-4-(5-isoquinolylsulfonyl)-1,4-perhydrodiazepine, 33, was comparable to diltiazem, which is used clinically as a vasodilator.This publication has 4 references indexed in Scilit:
- A post-calcium site of action for HA1004, a novel vasculorelaxantLife Sciences, 1986
- INTRACELLULAR CA++ ANTAGONIST, HA1004 - PHARMACOLOGICAL PROPERTIES DIFFERENT FROM THOSE OF NICARDIPINE1985
- VASODILATORY ACTION OF HA1004 [N-(2-GUANIDINOETHYL)-5-ISOQUINOLINESULFONAMIDE], A NOVEL CALCIUM-ANTAGONIST WITH NO EFFECT ON CARDIAC-FUNCTION1984
- Influence of Calcium Ions on Responses to Diltiazem in Coronary ArteriesThe Japanese Journal of Pharmacology, 1977